This study aimed to examine the expression and potential prognostic value of Survivin, as well as P53, BCL-2 and markers of the cellular process of apoptosis and proliferation, in pancreatic and ampullary cancers. This evidence concerns the gene TP53 and carcinoma of the ampulla of vater.